| 2.2 |
6.6 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 1.3 |
5.0 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.0 |
3.0 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.8 |
0.8 |
GO:0035385 |
axon midline choice point recognition(GO:0016199) Roundabout signaling pathway(GO:0035385) |
| 0.8 |
4.9 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.7 |
5.0 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.7 |
2.8 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.6 |
2.6 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.6 |
4.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.6 |
1.9 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.6 |
2.5 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.6 |
1.8 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.5 |
1.6 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.5 |
2.1 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.4 |
3.4 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.4 |
1.7 |
GO:0090083 |
inclusion body assembly(GO:0070841) regulation of inclusion body assembly(GO:0090083) |
| 0.4 |
1.2 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.4 |
1.1 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 |
1.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.4 |
1.9 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.4 |
1.1 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.4 |
2.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.4 |
1.4 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.4 |
2.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.4 |
1.1 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.3 |
1.0 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 |
1.5 |
GO:0032900 |
negative regulation of neurotrophin production(GO:0032900) |
| 0.3 |
0.9 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.3 |
0.9 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.3 |
3.4 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 |
0.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 |
0.3 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.3 |
0.8 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
1.1 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 |
0.3 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.3 |
0.8 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.3 |
0.8 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.3 |
0.5 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.3 |
1.0 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.2 |
0.5 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.2 |
1.0 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 |
1.7 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
0.7 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.2 |
1.1 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.2 |
1.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.2 |
0.2 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.2 |
0.2 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.2 |
0.4 |
GO:0046959 |
habituation(GO:0046959) |
| 0.2 |
1.3 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 |
0.7 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.2 |
0.2 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
1.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 |
2.6 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
0.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.2 |
GO:1900125 |
regulation of hyaluronan biosynthetic process(GO:1900125) |
| 0.2 |
0.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
0.8 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 |
4.5 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
3.5 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 |
1.2 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.2 |
5.0 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
0.6 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.2 |
0.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
0.6 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.2 |
2.2 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.2 |
0.2 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 |
0.8 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 |
0.6 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
1.2 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.6 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.2 |
0.8 |
GO:0014806 |
smooth muscle hyperplasia(GO:0014806) |
| 0.2 |
0.6 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.2 |
0.2 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.2 |
0.6 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
0.9 |
GO:1902913 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of developmental pigmentation(GO:0048070) positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 |
0.4 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.2 |
3.1 |
GO:2000553 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.2 |
0.5 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 |
1.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.5 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.2 |
0.5 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.2 |
2.0 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 |
0.2 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
0.5 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 |
0.7 |
GO:0035711 |
T-helper 1 cell activation(GO:0035711) |
| 0.2 |
0.4 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
| 0.2 |
0.2 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 |
0.7 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 |
1.4 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.2 |
1.4 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.2 |
0.2 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.2 |
0.5 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.2 |
0.3 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.2 |
0.8 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
1.0 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
1.7 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
0.2 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
| 0.2 |
0.8 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.3 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.2 |
1.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
1.0 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
0.6 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.2 |
0.2 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
1.0 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.8 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 |
0.3 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
0.6 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
0.6 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.2 |
1.5 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.2 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
1.2 |
GO:0043305 |
negative regulation of mast cell degranulation(GO:0043305) |
| 0.2 |
0.2 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.2 |
0.6 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
0.3 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.2 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.2 |
1.5 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 |
0.8 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.2 |
0.2 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.6 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.1 |
0.4 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.1 |
1.2 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.9 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.1 |
2.8 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.1 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
0.7 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
0.4 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.1 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 |
1.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.4 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
1.2 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.1 |
1.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
6.1 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
0.4 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.1 |
0.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.9 |
GO:0021784 |
postganglionic parasympathetic fiber development(GO:0021784) |
| 0.1 |
1.6 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.3 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 |
1.4 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 |
0.4 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.1 |
0.9 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.4 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 |
0.8 |
GO:2000538 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.1 |
0.8 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
1.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
1.5 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.1 |
1.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.5 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
1.3 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.3 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.1 |
0.5 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
0.3 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
1.1 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.4 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 |
1.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
2.9 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.1 |
0.5 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.1 |
0.4 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.4 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 |
0.1 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.1 |
1.1 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.1 |
0.4 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 |
0.1 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.1 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.7 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 |
0.5 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.1 |
0.1 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 |
0.3 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
1.5 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.4 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.1 |
0.4 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.1 |
0.6 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
0.8 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.6 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.8 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
2.3 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.4 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.4 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
0.4 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
1.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
1.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.4 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
0.4 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.4 |
GO:0050880 |
regulation of blood vessel size(GO:0050880) |
| 0.1 |
0.6 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
3.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
1.7 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.1 |
1.5 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.5 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.1 |
1.8 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.1 |
0.9 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.1 |
0.4 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.1 |
0.2 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.1 |
1.0 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.2 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.5 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.1 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.2 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.5 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.1 |
2.0 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.4 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.1 |
0.2 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 |
0.5 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.1 |
1.9 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.2 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
0.8 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:0045575 |
basophil activation(GO:0045575) |
| 0.1 |
1.9 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.6 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.6 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.3 |
GO:0090294 |
nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.1 |
0.8 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 |
0.1 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.1 |
1.0 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
1.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.2 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
1.9 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.8 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.6 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.1 |
0.6 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.1 |
0.3 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.1 |
0.1 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.1 |
0.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
1.0 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.2 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.1 |
0.3 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.1 |
0.2 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
0.8 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.1 |
0.7 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 |
0.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.8 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.1 |
0.4 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.4 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
1.1 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
0.5 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.1 |
0.2 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.1 |
0.4 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.1 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.1 |
0.6 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
1.9 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
2.5 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.1 |
3.7 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.1 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.1 |
0.8 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
2.2 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.2 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 |
0.8 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.6 |
GO:0045588 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
7.1 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.3 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 |
0.6 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.4 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
0.6 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.9 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.1 |
0.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
1.4 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.1 |
0.2 |
GO:2000318 |
positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.1 |
0.2 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.5 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
0.1 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.3 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.1 |
0.5 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.9 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.2 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.2 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
2.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
0.1 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.5 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.1 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.1 |
1.1 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.1 |
GO:2001183 |
negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.1 |
0.3 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.1 |
0.4 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.3 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.9 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.5 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 |
0.3 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.1 |
0.3 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.1 |
0.1 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.1 |
0.4 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 |
0.8 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.3 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.1 |
0.8 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
0.5 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
0.5 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.1 |
2.2 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 |
0.2 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 |
0.5 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.1 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 |
0.3 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.1 |
0.3 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.1 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.4 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
0.2 |
GO:0071317 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 |
0.4 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development involved in symbiotic interaction(GO:0044111) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.1 |
0.5 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.1 |
0.4 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.1 |
0.4 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.2 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
1.1 |
GO:1904869 |
regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 |
0.3 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) regulation of melanosome transport(GO:1902908) |
| 0.1 |
0.3 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.1 |
1.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.6 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.1 |
0.2 |
GO:0031635 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
| 0.1 |
1.4 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
1.3 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
1.7 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 |
1.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.4 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.7 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
1.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.9 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.5 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.3 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.1 |
0.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.4 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
1.1 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.1 |
0.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.3 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.1 |
0.2 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 |
1.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
1.4 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.3 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
0.1 |
GO:1902177 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.4 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 |
0.3 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
0.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.2 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.1 |
2.3 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
0.3 |
GO:1904588 |
cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.1 |
0.3 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
1.9 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.1 |
0.5 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
1.6 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.3 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.1 |
0.3 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 |
0.3 |
GO:0090290 |
regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 |
0.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.1 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.1 |
0.7 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
6.2 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.1 |
0.3 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.2 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.4 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.1 |
0.3 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.1 |
0.4 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
0.2 |
GO:1903515 |
calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.1 |
0.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
0.9 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.4 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
1.5 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.2 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.2 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.1 |
0.4 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 |
0.2 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.1 |
0.6 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.5 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
0.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
2.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.2 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 |
0.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.9 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.1 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.1 |
0.2 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.2 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.1 |
GO:1902804 |
negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.1 |
0.3 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.2 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.1 |
0.5 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
0.4 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.3 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.1 |
0.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.8 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.1 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 |
1.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
0.1 |
GO:0021942 |
cell migration in hindbrain(GO:0021535) hindbrain radial glia guided cell migration(GO:0021932) radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.4 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.1 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 |
0.1 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 |
0.4 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 |
0.1 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
1.0 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.3 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.1 |
0.3 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
2.6 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.3 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.1 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.1 |
0.5 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
0.2 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.1 |
0.4 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.1 |
0.2 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.1 |
0.2 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.1 |
0.4 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.1 |
0.4 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) |
| 0.1 |
0.2 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
| 0.1 |
0.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.3 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.1 |
1.1 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
0.1 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.1 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.3 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
0.4 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
2.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.4 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.1 |
0.7 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.1 |
1.0 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
0.5 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.1 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 |
0.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.1 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.1 |
0.8 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
1.0 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.9 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.4 |
GO:0060369 |
positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.1 |
0.4 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.1 |
0.3 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.1 |
0.1 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 |
0.3 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 |
0.3 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
| 0.1 |
0.3 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.3 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.2 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.2 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.1 |
0.4 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.7 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.1 |
GO:0035565 |
regulation of pronephros size(GO:0035565) |
| 0.1 |
2.3 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.1 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.3 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.1 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
1.4 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.1 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 |
0.5 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 |
0.6 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.2 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.1 |
0.1 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.1 |
0.2 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
0.1 |
GO:0033684 |
regulation of luteinizing hormone secretion(GO:0033684) negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
0.3 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.2 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.1 |
GO:0039656 |
modulation by virus of host gene expression(GO:0039656) |
| 0.1 |
0.1 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.3 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.3 |
GO:0032431 |
activation of phospholipase A2 activity(GO:0032431) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.3 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 |
0.1 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.1 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.2 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 |
0.1 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 |
0.1 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.1 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
0.1 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.1 |
0.1 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.1 |
0.1 |
GO:2000501 |
regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.1 |
0.2 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.6 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.1 |
0.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.1 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.1 |
0.5 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.1 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.2 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
0.6 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
4.4 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.7 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.1 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.1 |
0.1 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.1 |
0.3 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.2 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.4 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 |
0.2 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.1 |
0.5 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.2 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 |
0.8 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.1 |
GO:0002294 |
CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) |
| 0.1 |
0.1 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 |
0.3 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 |
0.2 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.1 |
0.1 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.1 |
0.1 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
1.7 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.1 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.1 |
0.2 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.1 |
1.9 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 |
0.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 |
0.9 |
GO:0072540 |
T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 |
0.1 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.1 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
0.5 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.3 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.2 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
0.5 |
GO:0031223 |
auditory behavior(GO:0031223) |
| 0.1 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.1 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.1 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.3 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 |
0.2 |
GO:2000364 |
central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.1 |
0.8 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.1 |
0.4 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.1 |
0.9 |
GO:0021544 |
subpallium development(GO:0021544) |
| 0.1 |
0.2 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.1 |
0.6 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.1 |
0.2 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.7 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.1 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.3 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 |
6.5 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
0.6 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 |
0.3 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.1 |
0.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.1 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
0.2 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.1 |
0.2 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.2 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.1 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.1 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.3 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 |
3.0 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.1 |
GO:0044788 |
modulation by host of viral process(GO:0044788) |
| 0.1 |
0.5 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.1 |
0.5 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
1.0 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.1 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.3 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.7 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
1.0 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.7 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
1.4 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.4 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.1 |
GO:0042269 |
regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.1 |
0.2 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
0.1 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.1 |
0.3 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.8 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.3 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.2 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.1 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
0.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.6 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.4 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
1.3 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.3 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.3 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.4 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.1 |
0.3 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.2 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
1.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.9 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.6 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.1 |
GO:0070233 |
negative regulation of T cell apoptotic process(GO:0070233) |
| 0.1 |
0.6 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.2 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.1 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
0.2 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.1 |
0.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
0.1 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.9 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
0.3 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.1 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.1 |
GO:0010880 |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.1 |
0.4 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 |
0.5 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.3 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
0.4 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 |
0.3 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.1 |
0.2 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 |
0.6 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.3 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.2 |
GO:0071418 |
uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) cellular response to amine stimulus(GO:0071418) |
| 0.1 |
2.5 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.3 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 |
0.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.0 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.0 |
0.2 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.0 |
0.1 |
GO:1901983 |
regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
| 0.0 |
0.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.5 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.1 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.0 |
0.1 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 |
0.0 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.0 |
0.0 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.1 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 |
0.0 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.0 |
0.1 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.0 |
0.3 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 |
0.2 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.2 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 |
0.2 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
1.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.0 |
0.4 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.0 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.0 |
0.7 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.0 |
1.4 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.3 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.2 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.0 |
0.0 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.0 |
0.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.0 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.0 |
1.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.0 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.0 |
0.2 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
| 0.0 |
0.6 |
GO:0048290 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 |
0.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.0 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.6 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
1.0 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.0 |
1.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.2 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.1 |
GO:1901016 |
regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 |
0.3 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.1 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.1 |
GO:0097009 |
energy homeostasis(GO:0097009) |
| 0.0 |
0.2 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.9 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.2 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.0 |
0.1 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 |
0.0 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.0 |
0.0 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.0 |
0.1 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 |
0.4 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
0.8 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.0 |
0.2 |
GO:0052312 |
modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
1.3 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.1 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 |
0.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.3 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.0 |
1.5 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.1 |
GO:1904888 |
cranial skeletal system development(GO:1904888) |
| 0.0 |
2.0 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 |
0.1 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.0 |
0.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.3 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.0 |
0.1 |
GO:1903674 |
regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.0 |
0.3 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.0 |
0.5 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.6 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.0 |
0.3 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.1 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.0 |
0.0 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.2 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.0 |
GO:0071373 |
cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.0 |
0.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.2 |
GO:1902499 |
regulation of protein autoubiquitination(GO:1902498) positive regulation of protein autoubiquitination(GO:1902499) |
| 0.0 |
0.3 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.3 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.1 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 |
0.0 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.6 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 |
0.0 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.1 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.0 |
0.1 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.0 |
0.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.2 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 0.0 |
0.1 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.0 |
0.2 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.0 |
0.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.0 |
0.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.6 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.0 |
GO:0061740 |
protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.0 |
0.2 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 |
0.2 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.3 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.0 |
0.0 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.0 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.1 |
GO:0021575 |
hindbrain morphogenesis(GO:0021575) |
| 0.0 |
0.2 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.1 |
GO:0019083 |
viral transcription(GO:0019083) |
| 0.0 |
0.1 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
1.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.0 |
0.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.0 |
0.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.3 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.3 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.0 |
0.1 |
GO:0032530 |
regulation of microvillus organization(GO:0032530) |
| 0.0 |
0.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 |
0.6 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.1 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.2 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.0 |
0.2 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 |
0.4 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.5 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.0 |
GO:0044254 |
multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.0 |
0.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 |
0.1 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 |
0.1 |
GO:0072679 |
thymocyte migration(GO:0072679) |
| 0.0 |
0.3 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.1 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.0 |
0.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.0 |
0.1 |
GO:0009755 |
hormone-mediated signaling pathway(GO:0009755) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.0 |
0.0 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.4 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.8 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.1 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 |
0.0 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.2 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.0 |
0.6 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.4 |
GO:0019184 |
glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.0 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.2 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.3 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.7 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.0 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.1 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.0 |
0.0 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.1 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.0 |
0.1 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
0.5 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 |
0.1 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.0 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.7 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.2 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.1 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.2 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.2 |
GO:0044026 |
DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
| 0.0 |
0.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 |
0.0 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 |
0.1 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.1 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.0 |
0.4 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.0 |
0.0 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 |
0.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.1 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.1 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.0 |
0.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.1 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.0 |
0.1 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.0 |
GO:0008291 |
acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.0 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.0 |
0.1 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 |
0.0 |
GO:0035112 |
genitalia morphogenesis(GO:0035112) |
| 0.0 |
0.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.0 |
0.6 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 |
0.6 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.1 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.0 |
0.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.1 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.0 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.2 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 |
0.2 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.1 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.0 |
0.6 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.0 |
0.1 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.0 |
0.2 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.0 |
0.2 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.2 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.4 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.9 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.1 |
GO:1902963 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.0 |
0.2 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.0 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 |
0.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.1 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.0 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.6 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.2 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.1 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.3 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.0 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.0 |
0.3 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.1 |
GO:0002545 |
microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) negative regulation of chronic inflammatory response(GO:0002677) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.1 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.0 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.0 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.2 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.0 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.0 |
0.2 |
GO:0098704 |
fructose import(GO:0032445) cellular response to fructose stimulus(GO:0071332) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 |
0.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.1 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.0 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.0 |
0.0 |
GO:0046321 |
positive regulation of fatty acid beta-oxidation(GO:0032000) positive regulation of fatty acid oxidation(GO:0046321) |
| 0.0 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.0 |
0.1 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.0 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.0 |
0.1 |
GO:0043303 |
mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.0 |
0.2 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.1 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 |
0.7 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.2 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.1 |
GO:0019860 |
uracil metabolic process(GO:0019860) |
| 0.0 |
0.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.3 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 |
1.3 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.0 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.0 |
0.1 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.1 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.0 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.0 |
GO:0070232 |
regulation of T cell apoptotic process(GO:0070232) |
| 0.0 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.8 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.2 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.1 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.0 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.1 |
GO:0048865 |
stem cell fate commitment(GO:0048865) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.1 |
GO:0090501 |
RNA phosphodiester bond hydrolysis(GO:0090501) |
| 0.0 |
0.1 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 |
0.4 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.1 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.0 |
0.2 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.1 |
GO:0060767 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.0 |
0.2 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.0 |
0.4 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.1 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.0 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.0 |
0.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.6 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.3 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.1 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.0 |
0.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.2 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.0 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 |
0.1 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.0 |
0.1 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.0 |
0.4 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.2 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.4 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.0 |
0.0 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.2 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 |
0.1 |
GO:0032446 |
protein modification by small protein conjugation(GO:0032446) |
| 0.0 |
0.1 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.0 |
0.1 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 |
0.1 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.0 |
0.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.6 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.2 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.0 |
0.1 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.7 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.0 |
0.1 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.4 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.3 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.2 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.0 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.0 |
0.2 |
GO:0019627 |
urea metabolic process(GO:0019627) |
| 0.0 |
1.9 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.7 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.0 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.1 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.0 |
0.1 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.0 |
0.2 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.0 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.1 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.0 |
0.1 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.0 |
0.1 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.0 |
0.1 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.0 |
0.1 |
GO:0032196 |
transposition(GO:0032196) |
| 0.0 |
0.1 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.2 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
0.1 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.2 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.0 |
0.1 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.3 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.2 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.0 |
0.2 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.0 |
0.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:0014911 |
positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 |
0.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 |
0.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.3 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 |
3.3 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.0 |
0.1 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.0 |
0.0 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.1 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 |
0.3 |
GO:0042446 |
hormone biosynthetic process(GO:0042446) |
| 0.0 |
0.9 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.0 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.0 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.0 |
0.0 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.0 |
0.1 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.0 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.0 |
0.2 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.2 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 |
1.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.0 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.2 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.1 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.0 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.0 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.1 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.0 |
0.0 |
GO:0010893 |
positive regulation of steroid biosynthetic process(GO:0010893) |
| 0.0 |
0.0 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.0 |
0.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
2.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.0 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.0 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
2.7 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.0 |
0.1 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.1 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.0 |
0.0 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.0 |
0.0 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.1 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.0 |
0.2 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.0 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.2 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.0 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.0 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 |
0.1 |
GO:0072275 |
metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.0 |
0.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.1 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.0 |
0.1 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 |
0.0 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.0 |
0.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.0 |
GO:1903313 |
positive regulation of mRNA metabolic process(GO:1903313) |
| 0.0 |
0.9 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.0 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.0 |
0.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.7 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0051664 |
spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.2 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.0 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.0 |
0.1 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.1 |
GO:0051023 |
regulation of immunoglobulin secretion(GO:0051023) |
| 0.0 |
1.6 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.0 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.1 |
GO:2001184 |
regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.2 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:0007620 |
copulation(GO:0007620) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.0 |
GO:0032075 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) positive regulation of nuclease activity(GO:0032075) |
| 0.0 |
0.1 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.0 |
0.2 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.1 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.0 |
0.1 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
1.1 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.2 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.0 |
0.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.1 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.0 |
0.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
1.4 |
GO:0072401 |
signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.2 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
0.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.3 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.0 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.0 |
GO:1904892 |
regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
| 0.0 |
0.2 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.3 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.0 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.2 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.0 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.2 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.1 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.0 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.1 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.0 |
0.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.0 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.0 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.0 |
0.2 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.1 |
GO:0072538 |
T-helper 17 type immune response(GO:0072538) |
| 0.0 |
0.0 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.1 |
GO:0002370 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.0 |
0.2 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.2 |
GO:1903204 |
neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
0.1 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.0 |
0.0 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.1 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.2 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
0.1 |
GO:0045425 |
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.0 |
0.0 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.0 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.1 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.0 |
0.2 |
GO:0018904 |
ether metabolic process(GO:0018904) |
| 0.0 |
0.0 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.2 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.0 |
0.1 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.1 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.0 |
0.0 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.0 |
0.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.2 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.0 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.0 |
0.1 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.1 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 |
0.1 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.0 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.0 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 |
0.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.0 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.0 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.2 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.2 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 |
0.4 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.0 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.0 |
0.0 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.0 |
0.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.2 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.2 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.3 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.0 |
0.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.1 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.0 |
0.0 |
GO:1990910 |
response to hypobaric hypoxia(GO:1990910) |
| 0.0 |
0.0 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.0 |
0.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.1 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.0 |
0.0 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 |
0.0 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.0 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.0 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 |
0.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.0 |
GO:0033046 |
negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
| 0.0 |
0.8 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.1 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.1 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 |
0.1 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 |
0.4 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.1 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.3 |
GO:1901988 |
negative regulation of cell cycle phase transition(GO:1901988) |
| 0.0 |
0.0 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.0 |
0.0 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.0 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.0 |
0.0 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.0 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.0 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.0 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.0 |
0.0 |
GO:0034130 |
toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.0 |
0.0 |
GO:2000667 |
positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.0 |
0.1 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.0 |
0.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.1 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.0 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.1 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.0 |
0.0 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 |
0.2 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.1 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.1 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.0 |
0.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.0 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.0 |
0.1 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.0 |
0.0 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.3 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 |
0.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.0 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.0 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.1 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.0 |
0.0 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.0 |
0.1 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.1 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.0 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
1.9 |
GO:1902749 |
regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.0 |
0.1 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.0 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.0 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.5 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.0 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.0 |
0.0 |
GO:0031062 |
positive regulation of histone methylation(GO:0031062) |
| 0.0 |
0.2 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.0 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.0 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.0 |
0.0 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.0 |
0.0 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
1.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.3 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.4 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.1 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0099540 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 |
0.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.0 |
0.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.0 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.1 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.0 |
GO:0044344 |
cellular response to fibroblast growth factor stimulus(GO:0044344) |
| 0.0 |
0.2 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.1 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
0.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.2 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.2 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.0 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
| 0.0 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.0 |
0.1 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.0 |
0.0 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.1 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 |
0.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.0 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.0 |
0.1 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.1 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.0 |
GO:1903860 |
negative regulation of dendrite extension(GO:1903860) |
| 0.0 |
0.1 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.0 |
GO:0044786 |
cell cycle DNA replication(GO:0044786) |
| 0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.0 |
GO:0044179 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 |
0.0 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.0 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
0.0 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.4 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.1 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.0 |
0.1 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 |
0.0 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.0 |
0.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.1 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.0 |
GO:0010820 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 |
0.6 |
GO:0044839 |
cell cycle G2/M phase transition(GO:0044839) |
| 0.0 |
0.1 |
GO:0042462 |
photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.2 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
1.7 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.0 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.0 |
0.0 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.1 |
GO:0070255 |
regulation of mucus secretion(GO:0070255) |
| 0.0 |
0.0 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.4 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.0 |
0.0 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |